0,867  0,003  NOS2 expression inhibitor
0,858  0,010  Apoptosis agonist
0,849  0,004  CYP1A2 inhibitor
0,820  0,005  CYP1A2 substrate
0,799  0,004  Caspase 3 stimulant
0,795  0,004  12-Lipoxygenase inhibitor
0,774  0,004  CTGF expression inhibitor
0,774  0,008  15-Lipoxygenase inhibitor
0,771  0,007  Radioprotector
0,753  0,005  Antineoplastic (melanoma)
0,749  0,005  Aldehyde oxidase inhibitor
0,745  0,004  AR expression inhibitor
0,742  0,005  Antineoplastic (glioma)
0,738  0,007  Prostate cancer treatment
0,744  0,015  Antineoplastic (breast cancer)
0,729  0,004  CYP2C19 inhibitor
0,740  0,019  Caspase 9 stimulant
0,727  0,011  Antineoplastic (colon cancer)
0,728  0,012  Antineoplastic (colorectal cancer)
0,730  0,015  Antineoplastic (lung cancer)
0,717  0,005  Antineoplastic (non-small cell lung cancer)
0,702  0,004  Carcinogenic, group 3
0,683  0,011  Antihypercholesterolemic
0,681  0,010  Aryl hydrocarbon receptor agonist
0,684  0,015  Antileukemic
0,670  0,007  Antioxidant
0,662  0,004  Topoisomerase II inhibitor
0,668  0,015  CYP2C9 substrate
0,648  0,004  Amylase inhibitor
0,655  0,014  Carcinogenic
0,646  0,006  Antineoplastic (brain cancer)
0,642  0,004  Breast cancer-resistant protein inhibitor
0,640  0,005  Hypoxia-inducible factor 1 alpha inhibitor
0,631  0,005  Antineoplastic (glioblastoma multiforme)
0,637  0,012  Chemopreventive
0,645  0,024  CYP3A4 substrate
0,628  0,011  Antineoplastic (cervical cancer)
0,612  0,004  Melanin inhibitor
0,614  0,010  CYP2C9 inhibitor
0,609  0,005  CYP3A4 inhibitor
0,599  0,005  Hepatoprotectant
0,593  0,011  NOS3 expression inhibitor
0,581  0,009  Vasodilator, coronary
0,581  0,011  Lipoxygenase inhibitor
0,582  0,013  Hepatic disorders treatment
0,579  0,012  Histamine release inhibitor
0,570  0,010  Free radical scavenger
0,572  0,017  Bone diseases treatment
0,555  0,005  MAO inhibitor
0,561  0,015  Antineoplastic (pancreatic cancer)
0,550  0,005  MAO A inhibitor
0,554  0,010  Amyloid beta aggregation inhibitor
0,555  0,012  Antineoplastic (multiple myeloma)
0,545  0,002  Histidine decarboxylase inhibitor
0,557  0,014  Antiosteoporotic
0,543  0,007  Antineoplastic (renal cancer)
0,542  0,006  P-glycoprotein inhibitor
0,546  0,018  Mutagenic
0,563  0,036  Transcription factor NF kappa B inhibitor
0,573  0,060  Alpha-glucosidase inhibitor
0,519  0,008  Pyruvate kinase inhibitor
0,521  0,018  Cytostatic
0,500  0,004  Aldehyde dehydrogenase inhibitor
0,512  0,021  Cardioprotectant
0,495  0,005  NOS3 expression enhancer
0,484  0,017  Nitric oxide antagonist
0,474  0,009  Tubulin antagonist
0,492  0,028  Antineoplastic (ovarian cancer)
0,469  0,014  Antihypertriglyceridemic
0,473  0,021  Proliferative diseases treatment
0,457  0,005  MAO B inhibitor
0,465  0,014  Antineoplastic (osteosarcoma)
0,488  0,044  Prostaglandin dehydrogenase inhibitor
0,467  0,025  Apoptosis antagonist
0,448  0,009  Skin whitener
0,449  0,017  Antimitotic
0,436  0,005  CYP2B6 inhibitor
0,435  0,004  Estrogen receptor beta antagonist
0,462  0,032  CYP2D6 substrate
0,431  0,001  DOPA decarboxylase inhibitor
0,424  0,002  Papain-like protease (SARS coronavirus) inhibitor
0,434  0,014  Antimutagenic
0,448  0,031  Spasmolytic
0,419  0,005  NADPH oxidase inhibitor
0,420  0,010  Monophenol monooxygenase inhibitor
0,408  0,005  Topoisomerase I inhibitor
0,425  0,023  DNA damaging
0,406  0,005  Topoisomerase II alpha inhibitor
0,420  0,020  Vasodilator
0,412  0,023  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,404  0,017  UGT1A1 substrate
0,396  0,011  Genotoxic
0,387  0,005  Estrogen antagonist
0,404  0,026  Tumour necrosis factor alpha release inhibitor
0,392  0,019  RNA-directed DNA polymerase inhibitor
0,398  0,028  Antipyretic
0,379  0,011  Bone formation stimulant
0,396  0,027  Antineoplastic (lymphoma)
0,378  0,014  Antineoplastic (carcinoma)
0,430  0,067  TNF expression inhibitor
0,401  0,041  CYP2C19 substrate
0,366  0,007  Antineoplastic (bone cancer)
0,422  0,067  Antibacterial
0,355  0,002  SULT1E1 substrate
0,366  0,014  UGT1A3 substrate
0,353  0,006  Carcinogenic, group 1
0,361  0,014  Antineoplastic (squamous cell carcinoma)
0,451  0,110  Antiinflammatory
0,372  0,032  Dyrk kinase inhibitor
0,341  0,004  Postmenopausal disorders treatment
0,370  0,033  Antihypoxic
0,395  0,059  Thioredoxin glutathione reductase inhibitor
0,372  0,039  Chemoprotective
0,357  0,027  Antineoplastic (lymphocytic leukemia)
0,324  0,011  Acetylcholinesterase inhibitor
0,327  0,015  Lipid peroxidase inhibitor
0,346  0,047  UGT1A9 substrate
0,337  0,041  Cardiodepressant
0,305  0,009  CDC-like kinase 1 inhibitor
0,318  0,025  Antihypotensive
0,296  0,006  Telomerase inhibitor
0,295  0,010  Carcinogenic, group 2B
0,378  0,093  5 Hydroxytryptamine release inhibitor
0,292  0,011  Heat shock protein 90 antagonist
0,303  0,022  Pneumotoxic
0,360  0,081  GABA C receptor rho-3 antagonist
0,342  0,066  ICAM1 expression inhibitor
0,279  0,004  Interleukin 5 antagonist
0,306  0,034  UDP-glucuronosyltransferase substrate
0,274  0,005  Antineoplastic (uterine cancer)
0,285  0,017  Heat shock protein 90 alpha antagonist
0,288  0,021  Protein-tyrosine phosphatase inhibitor
0,271  0,005  Macrophage migration inhibitory factor inhibitor
0,332  0,067  Streptokinase A inhibitor
0,299  0,035  Abortion inducer
0,308  0,048  Antineoplastic (liver cancer)
0,298  0,039  Clk dual-specificity kinase inhibitor
0,318  0,065  5 Hydroxytryptamine release stimulant
0,304  0,051  Hypoglycemic
0,310  0,068  CYP2D6 inhibitor
0,263  0,026  Cholinergic
0,260  0,025  UGT2B15 substrate
0,264  0,031  Neurotrophic factor enhancer
0,287  0,056  Antiamyloidogenic
0,246  0,015  VEGF expression inhibitor
0,281  0,051  DNA synthesis inhibitor
0,306  0,077  Antifungal
0,236  0,009  CF transmembrane conductance regulator agonist
0,230  0,007  MAP kinase kinase 4 inhibitor
0,227  0,007  Carcinogenic, group 2A
0,280  0,060  Sensitization
0,297  0,078  Respiratory analeptic
0,224  0,007  Estrogen receptor alpha antagonist
0,237  0,023  5 Hydroxytryptamine 3E antagonist
0,216  0,005  CDC-like kinase 3 inhibitor
0,253  0,045  CDC-like kinase 4 inhibitor
0,215  0,007  Estrogen agonist
0,242  0,036  Amyloid beta precursor protein antagonist
0,261  0,055  Psychostimulant
0,218  0,016  Xanthine oxidase inhibitor
0,225  0,024  Antifungal enhancer
0,264  0,066  Antiprotozoal (Leishmania)
0,245  0,049  VCAM1 expression inhibitor
0,339  0,144  DNA polymerase beta inhibitor
0,268  0,076  GST M1-1 substrate
0,267  0,078  UGT2B4 substrate
0,215  0,027  Antiprotozoal (Coccidial)
0,236  0,049  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,191  0,006  Alpha tubulin antagonist
0,222  0,039  Antiviral (Herpes)
0,190  0,010  DNA repair enzyme inhibitor
0,204  0,025  DNA intercalator
0,200  0,022  Antihemorrhagic
0,243  0,065  UGT1A6 substrate
0,182  0,008  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,224  0,053  Peroxidase inhibitor
0,198  0,030  Protein-tyrosine phosphatase 1B inhibitor
0,285  0,119  GST A substrate
0,176  0,011  CYP2A6 inhibitor
0,274  0,109  Antineoplastic (small cell lung cancer)
0,190  0,027  Cystathionine beta-synthase inhibitor
0,243  0,081  Vascular (periferal) disease treatment
0,215  0,053  Male reproductive disfunction treatment
0,181  0,019  Sulfotransferase substrate
0,196  0,039  Antiseptic
0,204  0,053  Mcl-1 antagonist
0,194  0,045  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,174  0,026  Butyrylcholinesterase inhibitor
0,166  0,019  Multidrug resistance-associated protein 1 inhibitor
0,158  0,013  HIV-1 integrase (3'-Processing) inhibitor
0,218  0,075  Interleukin antagonist
0,191  0,051  Phospholipase C inhibitor
0,195  0,055  Antineoplastic (gastric cancer)
0,179  0,041  SULT1A3 substrate
0,208  0,075  Cytotoxic
0,145  0,013  HIV-1 integrase (Strand Transfer) inhibitor
0,156  0,025  Antiviral (Influenza B)
0,189  0,059  Succinate dehydrogenase inhibitor
0,187  0,059  Liver fibrosis treatment
0,161  0,033  Interleukin 1b antagonist
0,140  0,013  Phosphodiesterase V inhibitor
0,292  0,166  DNA directed DNA polymerase inhibitor
0,207  0,082  Antiparasitic
0,199  0,075  Antiviral (Influenza)
0,286  0,162  Transcription factor inhibitor
0,222  0,101  Antiprotozoal (Trypanosoma)
0,146  0,027  Beta glucuronidase inhibitor
0,149  0,031  Antineoplastic antibiotic
0,145  0,029  Antineoplastic alkaloid
0,156  0,041  Antibacterial (Helicobacter pylori)
0,149  0,036  SULT1A1 substrate
0,209  0,098  Antiviral (West Nile virus)
0,227  0,119  Analeptic
0,168  0,061  Antiviral (Influenza A)
0,120  0,012  Phosphodiesterase VI inhibitor
0,146  0,040  Microtubule formation inhibitor
0,123  0,017  Beta tubulin antagonist
0,125  0,019  Glutamate decarboxylase inhibitor
0,123  0,018  Phosphodiesterase 5A inhibitor
0,143  0,038  Alcohol dehydrogenase substrate
0,150  0,045  Heat shock protein 70 antagonist
0,116  0,012  Xanthine dehydrogenase inhibitor
0,175  0,071  Dual specificity phosphatase inhibitor
0,184  0,080  Platelet adhesion inhibitor
0,259  0,156  Antiprotozoal
0,129  0,026  NAD(P)H dehydrogenase (quinone) inhibitor
0,134  0,033  Dementia treatment
0,105  0,007  Potassium channel Kv1.3 blocker
0,105  0,008  Estrogen receptor alpha agonist
0,209  0,112  Antineoplastic (sarcoma)
0,129  0,033  Vascular dementia treatment
0,130  0,034  Creatine kinase inhibitor
0,155  0,060  Mannose-6-phosphate isomerase inhibitor
0,112  0,019  GABA aminotransferase inhibitor
0,096  0,005  Endothelin receptor antagonist
0,113  0,023  Phosphodiesterase 11A inhibitor
0,113  0,023  Phosphodiesterase XI inhibitor
0,134  0,044  5-Lipoxygenase inhibitor
0,129  0,042  Sphingosine 1-phosphate receptor 2 agonist
0,187  0,100  Antineoplastic enhancer
0,093  0,007  DNA helicase inhibitor
0,239  0,152  Ulceration
0,098  0,012  Glutamate (mGluR7) antagonist
0,220  0,134  Antimycobacterial
0,131  0,045  Photosensitizer
0,170  0,085  LDLR expression enhancer
0,099  0,016  Neuraminidase inhibitor
0,171  0,088  Antihelmintic
0,099  0,016  CDC25B inhibitor
0,100  0,018  Aldose reductase inhibitor
0,115  0,038  Alcohol dehydrogenase inhibitor
0,079  0,003  Estrogen-related receptor beta antagonist
0,203  0,128  5 Hydroxytryptamine 1E antagonist
0,078  0,004  Endothelin B receptor antagonist
0,131  0,059  Alkylator
0,137  0,065  Cyclooxygenase 1 inhibitor
0,081  0,010  Acetyl-CoA transferase 2 inhibitor
0,153  0,082  Cystic fibrosis treatment
0,134  0,063  Cyclooxygenase 3 inhibitor
0,173  0,103  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,095  0,027  HIV-1 integrase inhibitor
0,108  0,041  ABCA1 expression enhancer
0,091  0,024  Antitreponemal
0,095  0,030  Lipase inhibitor
0,122  0,058  Interleukin 8 antagonist
0,078  0,015  Estrogen receptor beta agonist
0,134  0,072  Alkaline phosphatase inhibitor
0,070  0,011  Factor III inhibitor
0,084  0,027  Endocannabinoid uptake inhibitor
0,139  0,082  Adenylate cyclase stimulant
0,160  0,104  Antirickettsial
0,152  0,096  UGT2B10 substrate
0,122  0,066  Contraceptive female
0,196  0,142  Tyrosine 3 hydroxylase inhibitor
0,095  0,041  Myeloperoxidase inhibitor
0,088  0,035  SULT1A2 substrate
0,086  0,032  Premenstrual syndrome treatment
0,131  0,078  Erectile dysfunction treatment
0,128  0,075  Interleukin 4 antagonist
0,115  0,062  Skin irritative effect
0,057  0,005  Endothelin A receptor antagonist
0,140  0,089  UGT2B9 substrate
0,057  0,006  Dopamine autoreceptor agonist
0,073  0,023  Fatty acid synthase inhibitor
0,149  0,102  3C-like protease (Human coronavirus) inhibitor
0,087  0,041  Keratolytic
0,177  0,133  Peptidyltransferase inhibitor
0,068  0,023  Postcoital contraceptive
0,138  0,097  Aldose reductase substrate
0,126  0,087  Protein kinase stimulant
0,135  0,097  UGT1A4 substrate
0,136  0,098  UGT2B7 substrate
0,103  0,066  Expectorant
0,102  0,065  Urease inhibitor
0,154  0,120  Angiogenesis stimulant
0,058  0,023  CD45 antagonist
0,199  0,165  Cholesterol antagonist
0,049  0,016  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,122  0,092  Neurotrophic factor
0,050  0,022  Phosphodiesterase 6C inhibitor
0,051  0,024  Estradiol 17 beta-dehydrogenase inhibitor
0,130  0,104  Hexokinase inhibitor
0,066  0,042  Neuraminidase (influenza) inhibitor
0,053  0,029  Topoisomerase II beta inhibitor
0,210  0,187  Immunosuppressant
0,092  0,070  Phosphodiesterase 6D inhibitor
0,093  0,071  UGT2B11 substrate
0,049  0,028  Carbonic anhydrase VII inhibitor
0,061  0,041  Aromatase inhibitor
0,087  0,067  Restless leg syndrome treatment
0,147  0,127  Phobic disorders treatment
0,031  0,012  Sodium/glucose cotransporter 2 inhibitor
0,123  0,104  Skeletal muscle relaxant
0,074  0,056  GABA B receptor agonist
0,087  0,071  Antiviral (Hepatitis A)
0,077  0,061  Carbonic anhydrase VI inhibitor
0,070  0,056  CDC25A inhibitor
0,101  0,088  Antiviral (Coronavirus)
0,101  0,088  Antiviral (SARS coronavirus)
0,113  0,100  Interleukin 1 antagonist
0,116  0,104  Psychosexual dysfunction treatment
0,049  0,040  CXC chemokine 1 receptor antagonist
0,093  0,084  Choleretic
0,112  0,104  Acaricide
0,127  0,119  Dual specificity phosphatase 3 inhibitor
0,165  0,157  MAP-kinase-activated kinase 5 inhibitor
0,152  0,146  Antialcoholic
0,104  0,098  Toll-Like receptor 2 antagonist
0,055  0,049  Heat shock protein 90 beta antagonist
0,021  0,017  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,056  0,052  Ryanodine receptor antagonist
0,082  0,080  Uric acid excretion stimulant
0,136  0,134  Cyclin-dependent kinase 3 inhibitor
0,064  0,063  SULT2A1 substrate
0,129  0,127  Ca2+-transporting ATPase inhibitor
0,024  0,023  Sodium/glucose cotransporter inhibitor

